Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:VBLT

Vascular Biogenics (VBLT) Stock Price, News & Analysis

Vascular Biogenics logo

About Vascular Biogenics Stock (NASDAQ:VBLT)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.16
$5.46
52-Week Range
N/A
Volume
161,505 shs
Average Volume
2.19 million shs
Market Capitalization
$423.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VBLT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vascular Biogenics and its competitors with MarketBeat's FREE daily newsletter.

VBLT Stock News Headlines

The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.
Notable Labs Closes Merger Transaction With VBL Therapeutics
Vascular Biogenics Rises on Presentation Hype
See More Headlines

VBLT Stock Analysis - Frequently Asked Questions

Vascular Biogenics Ltd. (NASDAQ:VBLT) announced its quarterly earnings data on Monday, November, 15th. The biopharmaceutical company reported ($0.09) earnings per share for the quarter, beating the consensus estimate of ($0.11) by $0.02. The biopharmaceutical company had revenue of $0.20 million for the quarter, compared to the consensus estimate of $0.20 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vascular Biogenics investors own include T2 Biosystems (TTOO), SCYNEXIS (SCYX), Onconova Therapeutics (ONTX), OPKO Health (OPK), VBI Vaccines (VBIV), TherapeuticsMD (TXMD) and Vaxart (VXRT).

Company Calendar

Last Earnings
11/15/2021
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:VBLT
Previous Symbol
NASDAQ:VBLX
CIK
1603207
Employees
7
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.21)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$32.30 million
Net Margins
N/A
Pretax Margin
-3,317.05%
Return on Equity
-73.45%
Return on Assets
-54.11%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.63
Quick Ratio
4.63

Sales & Book Value

Annual Sales
$660 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.32 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
77,640,000
Free Float
72,881,000
Market Cap
$423.91 million
Optionable
Optionable
Beta
0.77

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:VBLT) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners